Does Age Impact Safety and Efficacy During Pulse-Field Ablation for Atrial Fibrillation?
| Title: | Does Age Impact Safety and Efficacy During Pulse-Field Ablation for Atrial Fibrillation? |
|---|---|
| Authors: | Dello Russo A; Tondo C; Bianchi S; Schillaci V; Iacopino S; Casella M; Rossillo A; Maggio R; Themistoclakis S; Bertini M; Russo M; Volpicelli M; Viola G; Rordorf R; Schiavone M; Valeri Y; Colella J; Rossi P; Tundo F; Zingarini G; De Simone A; Bianchini L; Di Vilio A; Compagnucci P; Malacrida M; Zucchelli G; Solimene F |
| Contributors: | Dello Russo, A; Tondo, C; Bianchi, S; Schillaci, V; Iacopino, S; Casella, M; Rossillo, A; Maggio, R; Themistoclakis, S; Bertini, M; Russo, M; Volpicelli, M; Viola, G; Rordorf, R; Schiavone, M; Valeri, Y; Colella, J; Rossi, P; Tundo, F; Zingarini, G; De Simone, A; Bianchini, L; Di Vilio, A; Compagnucci, P; Malacrida, M; Zucchelli, G; Solimene, F |
| Publication Year: | 2025 |
| Collection: | Università Politecnica delle Marche: IRIS |
| Subject Terms: | age; atrial fibrillation; electroporation; older patient; pulsed‐field ablation |
| Description: | Background There is no evidence evaluating efficiency, effectiveness, and safety outcomes in older patients in the context of pulsed-field ablation technology for the ablation of atrial fibrillation. We aimed to compare safety, efficacy, and acute and long-term outcomes of pulsed-field ablation in older patients (>= 75 years) with younger ones. Methods We enrolled consecutive patients who had undergone atrial fibrillation ablation with the pulsed-field ablation FARAPULSE system (Boston Scientific) at 15 centers. Patients were stratified by age (= 75 years) and efficacy and safety profiles of these groups were compared. Results A total of 1082 patients were included: 108 (10%) were >= 75 years old, 374 (34.6%) were 65-74 years old and 600 (55.4%) were |
| Document Type: | article in journal/newspaper |
| Language: | unknown |
| Relation: | info:eu-repo/semantics/altIdentifier/pmid/40265595; info:eu-repo/semantics/altIdentifier/wos/WOS:001482876700001; volume:14; issue:9; numberofpages:11; journal:JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE; https://hdl.handle.net/11566/348957; https://pubmed.ncbi.nlm.nih.gov/40265595/ |
| DOI: | 10.1161/JAHA.124.037959 |
| Availability: | https://hdl.handle.net/11566/348957; https://doi.org/10.1161/JAHA.124.037959; https://pubmed.ncbi.nlm.nih.gov/40265595/ |
| Rights: | info:eu-repo/semantics/openAccess ; license:Creative commons ; license uri:http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| Accession Number: | edsbas.56C1AE3D |
| Database: | BASE |